<wbr id="bqcnu"></wbr>
      1. <video id="bqcnu"><input id="bqcnu"></input></video>
          1. <video id="bqcnu"><input id="bqcnu"></input></video>
          2. 歡迎光臨華藥國際醫藥有限公司!

            華藥國際醫藥

            news

            products

            Contact Us

            E-mail:hygj@ncpc.biz

            Website:www.nxpnetsolutions.com/en

            Add:217-1,East Heping Road, Shijiangzhuang, Hebei P.R.China.050015

            Recombinant Human Anti Rabies Virus Monoclonal Antibody Injection by NCPC

            position: home >> News >> Company News

            Recombinant Human Anti Rabies Virus Monoclonal Antibody Injection by NCPC

            pubdate:2016-12-24 author: clicks:

            Fill A Vacancy in China

            The important project of Recombinant Human Anti Rabies Virus Monoclonal Antibody Injection from NCPC is supported by Ministry of Science and Technology, has been developed in 6 years, carried out the clinical trial for about 3 years, the results of the accomplished phase Ia of clinical trial indicate that the tolerance for the volunteers to Recombinant Human Anti Rabies Virus Monoclonal Antibody Injection is good, the adverse reaction after injection hasn’t been observed during the trial, the drug safety to human has been obtained the preliminary confirmation.

            Recently Viewed:

            related products:

            related news:

            人妻少妇精品视频一区二区三区_欧美午夜视频_www黄色视频_久久久一级片
              <wbr id="bqcnu"></wbr>
              1. <video id="bqcnu"><input id="bqcnu"></input></video>
                  1. <video id="bqcnu"><input id="bqcnu"></input></video>